Literature DB >> 28752367

Update on Quinolone Allergy.

Inmaculada Doña1, Esther Moreno2,3, Natalia Pérez-Sánchez4, Inmaculada Andreu5, Dolores Hernández Fernandez de Rojas6, María José Torres4.   

Abstract

PURPOSE OF REVIEW: Quinolones are a group of synthetic antibiotics widely use as first-line treatment for many infections. There has been an increase in the incidence of hypersensitivity reactions to quinolones in recent years, likely due to increased prescription. The purpose of this review is to summarize the clinical pictures, the methods used for diagnosing and the management of allergic reactions to quinolones. RECENT
FINDINGS: Allergic reactions to quinolones can be immediate or delayed, being anaphylaxis and maculopapular exanthema respectively the most frequent clinical entities. A precise diagnosis is particularly difficult since clinical history is often unreliable, skin tests can induce false-positive results, and commercial in vitro test are not well validated. Therefore, drug provocation testing is considered the gold standard to establish diagnosis, which is not a risk-free procedure. Cross-reactivity between quinolones is difficult to predict due to the small number of patients included in the few published studies. Moreover, hypersensitivity to quinolones has also been associated with beta-lactam and neuromuscular blocking agent allergies, although further studies are needed to understand the underlying mechanisms. Avoidance of the culprit quinolone is indicated in patients with a diagnosis of hypersensitivity to these drugs. When quinolone treatment is the only therapeutic option available, desensitization is necessary. This review summarizes the complex diagnostic approach and management of allergic reactions to quinolones.

Entities:  

Keywords:  Anaphylaxis; Basophil activation test; Drug provocation test; Maculopapular exanthema; Quinolone; Skin test

Mesh:

Substances:

Year:  2017        PMID: 28752367     DOI: 10.1007/s11882-017-0725-y

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  72 in total

1.  Fixed drug eruption from quinolones with a positive lesional patch test to ciprofloxacin.

Authors:  A Rodríguez-Morales; A A Llamazares; R P Benito; C M Cócera
Journal:  Contact Dermatitis       Date:  2001-04       Impact factor: 6.600

2.  Immediate hypersensitivity to levofloxacin diagnosed through skin prick test.

Authors:  Eloina González-Mancebo; Montserrat Fernández-Rivas
Journal:  Ann Pharmacother       Date:  2003-12-30       Impact factor: 3.154

3.  Fixed drug eruption due to norfloxacin and cross-reactivity with other quinolones.

Authors:  L Sánchez-Morillas; P Rojas Pérez-Ezquerra; M L González Morales; C Mayorga; R González-Mendiola; J J Laguna Martínez
Journal:  Allergol Immunopathol (Madr)       Date:  2012-01-21       Impact factor: 1.667

Review 4.  Mechanisms of action of antimicrobials: focus on fluoroquinolones.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

5.  Toxic epidermal necrolysis reaction associated with the use of moxifloxacin.

Authors:  Amanda Howard-Thompson; Bryan Cartmell; Katie J Suda
Journal:  Int J Antimicrob Agents       Date:  2014-05-02       Impact factor: 5.283

6.  Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature.

Authors:  Brenda Chang; Sandra R Knowles; Elizabeth Weber
Journal:  Ann Pharmacother       Date:  2010-03-16       Impact factor: 3.154

7.  Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins.

Authors:  T D Fernández; M J Torres; N Blanca-López; J L Rodríguez-Bada; E Gomez; G Canto; C Mayorga; M Blanca
Journal:  Allergy       Date:  2009-02       Impact factor: 13.146

8.  Diagnostic testing in suspected fluoroquinolone hypersensitivity.

Authors:  C S Seitz; E B Bröcker; A Trautmann
Journal:  Clin Exp Allergy       Date:  2009-09-03       Impact factor: 5.018

Review 9.  A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.

Authors:  P Ball; L Mandell; G Patou; W Dankner; G Tillotson
Journal:  Int J Antimicrob Agents       Date:  2004-05       Impact factor: 5.283

10.  Fixed drug eruptions caused by cross-reactive quinolones.

Authors:  P Deepa Kameswari; Nitya Selvaraj; Mangaiarkkarasi Adhimoolam
Journal:  J Basic Clin Pharm       Date:  2014-03
View more
  12 in total

Review 1.  Update on Quinolone Allergy: A Complementary Note.

Authors:  Athina L Van Gasse; Vito Sabato; Margaretha Faber; Margo M Hagendorens; Didier G Ebo
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-03       Impact factor: 4.806

Review 2.  BAT in the Diagnosis of Drug Allergy: a Novel Tool in Clinical Daily Practice?

Authors:  Lucila Campos; Violeta Régnier Galvão; Jorge Kalil; Mariana Castells; Pedro Giavina-Bianchi
Journal:  Curr Allergy Asthma Rep       Date:  2019-03-11       Impact factor: 4.806

Review 3.  Quinolones as a Potential Drug in Genitourinary Cancer Treatment-A Literature Review.

Authors:  Tomasz Kloskowski; Sylwia Frąckowiak; Jan Adamowicz; Kamil Szeliski; Marta Rasmus; Tomasz Drewa; Marta Pokrywczyńska
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

4.  Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic.

Authors:  Matthew S Krantz; Cosby A Stone; Roger Yu; Sarah N Adams; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2020-09-24

5.  A practical management of children with antibiotic allergy.

Authors:  Elisabetta Calamelli; Carlo Caffarelli; Fabrizio Franceschini; Francesca Saretta; Fabio Cardinale; Roberto Bernardini; Lucia Liotti; Francesca Mori; Giuseppe Crisafulli; Silvia Caimmi; Paolo Bottau
Journal:  Acta Biomed       Date:  2019-01-28

6.  Female Asthmatic Patients Have Higher Risk to Develop Gemifloxacin-Associated Skin Rash, Highlighting Unique Delayed Onset Characteristics.

Authors:  Chiou-Mei Wu; Po-Ju Wei; Yu-Ting Shen; Hsu-Liang Chang; Ying-Ming Tsai; Hung-Fang Pan; Yong-Chieh Chang; Yu-Ching Wei; Chih-Jen Yang
Journal:  Antibiotics (Basel)       Date:  2019-08-31

Review 7.  Quinolone Allergy.

Authors:  Edoabasi U McGee; Essie Samuel; Bernadett Boronea; Nakoasha Dillard; Madison N Milby; Susan J Lewis
Journal:  Pharmacy (Basel)       Date:  2019-07-19

Review 8.  Sterilization and disinfection methods for decellularized matrix materials: Review, consideration and proposal.

Authors:  Meihan Tao; Tianrang Ao; Xiaoyan Mao; Xinzhu Yan; Rabia Javed; Weijian Hou; Yang Wang; Cong Sun; Shuang Lin; Tianhao Yu; Qiang Ao
Journal:  Bioact Mater       Date:  2021-02-27

9.  Ciprofloxacin and Levofloxacin as Potential Drugs in Genitourinary Cancer Treatment-The Effect of Dose-Response on 2D and 3D Cell Cultures.

Authors:  Tomasz Kloskowski; Kamil Szeliski; Zuzanna Fekner; Marta Rasmus; Paweł Dąbrowski; Aleksandra Wolska; Natalia Siedlecka; Jan Adamowicz; Tomasz Drewa; Marta Pokrywczyńska
Journal:  Int J Mol Sci       Date:  2021-11-04       Impact factor: 5.923

10.  A practical method of drug provocation testing to prove tolerance to alternative drugs in drug hypersensitivity

Authors:  Ebru Çelebioğlu; Özge Öztürk Aktaş; Gül Karakaya; Ali Fuat Kalyoncu
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.